斋月间歇性禁食对患者的影响:一项临床和实验室研究
Sally Shaaban1, Shorouk Mohsen2, Asmaa Ayman3
1Neurology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Epilepsy & behavior : E&B
|May 18, 2025
概括
斋月禁食可能会增加发作控制不良的患者的发作风险,特别是那些服用多种药物或更长时间禁食的人. 禁食期间的电解质和水分变化可能会影响发作的发生.
科学领域:
- 神经学 神经学
- 临床医学 临床医学
- 代谢研究 代谢研究
背景情况:
- 治疗需要仔细考虑生活方式因素,包括像斋月禁食这样的宗教习俗.
- 了解禁食对发作频率的生理影响对于患者护理至关重要.
研究的目的:
- 评估在斋月期间患的穆斯林患者中发作频率的变化.
- 评估在斋月禁食期间关键生理血液参数的变化.
主要方法:
- 一项前性队列研究,涉及20名观察斋月斋戒的成年患者.
- 在斋月前,斋月期间和斋月后期间监测了发作频率.
- 实验室测量包括在禁食和非禁食状态期间的血红素,,和β-基酸盐水平.
主要成果:
- 三分之一的参与者仍然没有发作;然而,长时间的禁食与发作风险增加相关 (P=0.02).
- 与单疗法相比,多疗法患者的发作概率较高 (P=0.03).
- 禁食导致beta-hydroxybutyrate,和血红素水平显著增加 (P<0.001),而保持稳定 (P=0.4). 较高的水平与发作有关 (P=0.005).
结论:
- 斋月禁食可能会增加患有控制不良的患者的发作风险,特别是那些接受多疗法和长时间禁食的患者.
- 潜在的促成因素包括在禁食期间改变的水分状态和电解质水平.
- 需要进一步的研究来阐明连接斋月禁食和活动的确切机制.
更多相关视频
10:23Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
Published on: June 23, 2023
1.8K
08:06Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
Published on: November 27, 2019
8.8K
相关概念视频
Arteries of the Lower Limbs
173
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
173
Antiepileptic Drugs: Glutamate Antagonists
264
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
264
Metabolic States of the Body: Fasting and Starvation
989
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
989
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators
297
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
297
